MedTrace Logo

Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

NCT02238470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-08-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether Magnetic Resonance Imaging may predict the risk of Intracerebral Hemorrhage for patients with ischemic stroke who receive indefinite oral anticoagulation

Conditions

Interventions

DRUG

oral anticoagulants

Comparison of patients receiving oral anticoagulants with or without microbleeds in magnetic resonance imaging

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Joan Martí-Fàbregas, MD,PhD · Biomedical Research Institute Sant Pau (IIB Sant Pau)

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Italy
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02238470 on ClinicalTrials.gov